Breast cancer cells produce parathyroid hormone-related peptide (PTHrP) that activates osteoblasts to produce receptor activator of nuclear factor kappa-B ligand (RANKL) and downregulate osteoprotegerin (OPG). Here, TNFRSF11B is linked to breast cancer.